LIPAGLYN 4 MG (Saroglitazar (4mg))

Lipaglyn Tablet is a medication indicated for the management of Noncirrhotic Non-Alcoholic Steatohepatitis and Non-alcoholic Fatty Liver Disease (NAFLD) associated with conditions such as obesity, Type 2 Diabetes Mellitus, Dyslipidemia, or Metabolic Syndrome. It is also utilized in addressing high cholesterol levels that occur in individuals with diabetes, known as diabetic dyslipidemia. For optimal efficacy, Lipaglyn Tablet can be administered either with or without food, ideally at the same time each day. It is essential for patients to adhere to this regimen and not discontinue use without a physician’s advice. Maintaining a balanced diet and a consistent exercise routine, as advised by a healthcare provider, is crucial while taking this medication, as these lifestyle factors play a significant role in achieving and sustaining a healthy weight, which in turn aids in protecting liver health. Some patients may experience mild side effects such as flatulence, indigestion, abdominal swelling, elevated body temperature, and weakness. Although generally not severe, patients should seek medical guidance if any side effects are persistent or cause concern. Before commencing therapy, it is important to inform the prescribing physician of any past or present kidney, heart, or pancreas-related conditions, as well as alcohol consumption habits. Pregnant or nursing individuals should also discuss potential risks with their healthcare provider. Regular monitoring through tests, including liver and kidney function assessments, as well as blood glucose levels, may be necessary to ensure the medication is functioning effectively.